{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:27:58Z","timestamp":1777418878692,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.intimp.2014.03.008","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T12:32:26Z","timestamp":1395750746000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Xiaoyan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengyang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.03.008_bb0005","first-page":"45","article-title":"Pathogenesis of rabies","volume":"292","author":"Dietzschold","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.intimp.2014.03.008_bb0010","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","volume":"187","author":"Meslin","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.intimp.2014.03.008_bb0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0264-410X(96)00314-3","article-title":"A global review of rabies vaccines for human use","volume":"15","author":"Dreesen","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.intimp.2014.03.008_bb0020","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.intimp.2014.03.008_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/421563","article-title":"A tale of two worlds: public health management decisions in human rabies prevention","volume":"39","author":"Rupprecht","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.intimp.2014.03.008_bb0030","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1017\/S0950268807000131","article-title":"Inferior rabies vaccine quality and low immunization coverage in dogs (Canis familiaris) in China","volume":"136","author":"Hu","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"04","key":"10.1016\/j.intimp.2014.03.008_bb0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1142\/S0218339008002666","article-title":"Two dynamic models about rabies between dogs and human","volume":"16","author":"Wang","year":"2008","journal-title":"J Biol Syst"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0040","first-page":"281","article-title":"Economics of human and canine rabies elimination: guidelines for programme orientation","volume":"68","author":"B\u00f6gel","year":"1990","journal-title":"Bull World Health Organ"},{"issue":"17\u201318","key":"10.1016\/j.intimp.2014.03.008_bb0045","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0264-410X(02)00778-8","article-title":"A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries","volume":"21","author":"Cleaveland","year":"2003","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.intimp.2014.03.008_bb0050","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.vaccine.2012.03.069","article-title":"Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review","volume":"30","author":"Davlin","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.intimp.2014.03.008_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3201\/eid1112.050271","article-title":"Pivotal role of dogs in rabies transmission, China","volume":"11","author":"Tang","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.intimp.2014.03.008_bb0060","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3201\/eid1508.081426","article-title":"Reemerging rabies and lack of systemic surveillance in People's Republic of China","volume":"15","author":"Wu","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.intimp.2014.03.008_bb0065","doi-asserted-by":"crossref","first-page":"e20891","DOI":"10.1371\/journal.pone.0020891","article-title":"Analysis of rabies in China: transmission dynamics and control","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2014.03.008_bb0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0035-9203(93)90099-C","article-title":"Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective antibody response","volume":"87","author":"Sage","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vetmic.2008.06.024","article-title":"Comparison of antibody responses after vaccination with two inactivated rabies vaccines","volume":"133","author":"Minke","year":"2009","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.intimp.2014.03.008_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"issue":"11\u201312","key":"10.1016\/j.intimp.2014.03.008_bb0085","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0264-410X(99)00352-7","article-title":"DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL)","volume":"18","author":"Lodmell","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2014.03.008_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1142\/S0192415X73000279","article-title":"An introductory note to ginseng","volume":"1","author":"Li","year":"1973","journal-title":"Am J Chin Med"},{"issue":"36","key":"10.1016\/j.intimp.2014.03.008_bb0095","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1016\/j.vaccine.2009.06.033","article-title":"Adjuvant activities of saponins from traditional Chinese medicinal herbs","volume":"27","author":"Song","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.intimp.2014.03.008_bb0100","first-page":"1539","article-title":"Panax ginseng","volume":"68","author":"Kiefer","year":"2003","journal-title":"Am Fam Physician"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2014.03.008_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2006.08.056","article-title":"Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats","volume":"550","author":"Cho","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2014.03.008_bb0110","doi-asserted-by":"crossref","first-page":"H851","DOI":"10.1152\/ajpheart.01242.2007","article-title":"Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes","volume":"295","author":"Wang","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11\u201312","key":"10.1016\/j.intimp.2014.03.008_bb0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0264-410X(02)00518-2","article-title":"Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants","volume":"21","author":"Rivera","year":"2003","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.intimp.2014.03.008_bb0120","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1016\/j.vaccine.2012.03.052","article-title":"Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway","volume":"30","author":"Su","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.intimp.2014.03.008_bb0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.vaccine.2006.09.054","article-title":"Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice","volume":"25","author":"Sun","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.intimp.2009.12.009","article-title":"Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re","volume":"10","author":"Song","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2014.03.008_bb0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/cyto.1998.0426","article-title":"Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR","volume":"11","author":"Overbergh","year":"1999","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1440-1711.2001.01002.x","article-title":"Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I","volume":"79","author":"Yin","year":"2001","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"10.1016\/j.intimp.2014.03.008_bb0145","first-page":"954","article-title":"Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification","volume":"24","author":"Morrison","year":"1998","journal-title":"Biotechniques"},{"issue":"9","key":"10.1016\/j.intimp.2014.03.008_bb0150","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.intimp.2014.03.008_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","article-title":"Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re","volume":"135","author":"Qu","year":"2013","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.intimp.2014.03.008_bb0160","series-title":"Veterinary immunology: an introduction","author":"Tizard","year":"1992"},{"issue":"21","key":"10.1016\/j.intimp.2014.03.008_bb0165","doi-asserted-by":"crossref","first-page":"11533","DOI":"10.1128\/JVI.00615-12","article-title":"Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection","volume":"86","author":"Dorfmeier","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.intimp.2014.03.008_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.15.1.297","article-title":"Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches","volume":"15","author":"Constant","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/JMN:29:3:185","article-title":"The innate immune facet of brain","volume":"29","author":"Lafon","year":"2006","journal-title":"J Mol Neurosci"},{"issue":"2","key":"10.1016\/j.intimp.2014.03.008_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/MB:21:2:129","article-title":"The development and use of vaccine adjuvants","volume":"21","author":"Edelman","year":"2002","journal-title":"Mol Biotechnol"},{"issue":"3","key":"10.1016\/j.intimp.2014.03.008_bb0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1086\/322032","article-title":"Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization","volume":"184","author":"Gottwein","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.intimp.2014.03.008_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.arcmed.2011.10.009","article-title":"Intranasal anti-rabies DNA immunization promotes a Th1-related cytokine stimulation associated with plasmid survival time","volume":"42","author":"Feria-Romero","year":"2011","journal-title":"Arch Med Res"},{"issue":"7","key":"10.1016\/j.intimp.2014.03.008_bb0195","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JVI.65.7.3429-3434.1991","article-title":"Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus","volume":"65","author":"Perry","year":"1991","journal-title":"J Virol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T19:55:45Z","timestamp":1597607745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1567576914001118"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.03.008","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}